Evidence for risk of cardiomyopathy with hydroxychloroquine

Abstract

Get full access to this article

View all access options for this article.

References

Gasparyan

Ayvazyan

Cocco

Kitas

. Adverse cardiovascular effects of antirheumatic drugs: Implications for clinical practice and research. Curr Pharm Des 2012; 18: 1543–1555.

Yildirim-Toruner

Diamond

. Current and novel therapeutics in the treatment of systemic lupus erythematosus. J Allergy Clin Immunol 2011; 127: 303–312.

Ben-Zvi

Kivity

Langevitz

Shoenfeld

. Hydroxychloroquine: From malaria to autoimmunity. Clin Rev Allergy Immunol 2012; 42: 145–153.

Gasparyan

Stavropoulos-Kalinoglou

Mikhailidis

Toms

Douglas

Kitas

. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vas Pharmacol 2010; 8: 437–449.

Schneider

Schmitt

Richter

. Prevalence and correlates of inflammatory arthritis in Germany: Data from the First National Health Survey. Rheumatol Int 2006; 27: 29–38.

John

Kitas

Toms

Goodson

. Cardiovascular co-morbidity in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2009; 23: 71–82.

Tanay

Leibovitz

Frayman

Zimlichman

Shargorodsky

Gavish

. Vascular elasticity of systemic lupus erythematosus patients is associated with steroids and hydroxychloroquine treatment. Ann N Y Acad Sci 2007; 1108: 24–34.

Costedoat-Chalumeau

Hulot

Amoura

Delcourt

Maisonobe

Dorent

. Cardiomyopathy related to antimalarial therapy with illustrative case report. Cardiology 2007; 107: 73–80.

Nord

Shah

Rinaldi

Weisman

. Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: A report of 2 cases and review of the literature. Semin Arthritis Rheum 2004; 33: 336–351.

10.

Cotroneo

Sleik

Rodriguez

Klein

. Hydroxychloroquine-induced restrictive cardiomyopathy. Eur J Echocardiography 2007; 8: 247–251.

11.

Newton-Cheh

Lin

Baggish

Wang

. Case records of the Massachusetts General Hospital. Case 11-2011: A 47-year-old man with systemic lupus erythematosus and heart failure. N Engl J Med 2011; 364: 1450–1460.

12.

U.S. Food and Drug Administration. Adverse Events Reporting System, http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm070093.htm (2010, accessed July 2012).

13.

Evans

Waller

Davis

. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10: 483–486.

14.

Moore

Cohen

Furberg

. Serious adverse drug events reported to the Food and Drug Administration, 1998–2005. Arch Intern Med 2007; 167: 1752–1759.

15.

Figueredo

. Chemical cardiomyopathies: The negative effects of medications and nonprescribed drugs on the heart. Am J Med 2011; 124: 480–488.